OptimizeRx.png
OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET
April 26, 2023 08:00 ET | OptimizeRx Corporation
ROCHESTER, Mich., April 26, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx.png
OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report
April 04, 2023 08:01 ET | OptimizeRx Corporation
ROCHESTER, Mich., April 04, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx.png
Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year
March 29, 2023 09:20 ET | OptimizeRx Corporation
ROCHESTER, Mich., March 29, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx.png
OptimizeRx Authorizes $15 Million Share Repurchase Program
March 14, 2023 07:30 ET | OptimizeRx Corporation
ROCHESTER, Mich., March 14, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx.png
OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
March 09, 2023 08:01 ET | OptimizeRx Corporation
ROCHESTER, Mich., March 09, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx.png
OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
March 08, 2023 16:01 ET | OptimizeRx Corporation
Q4 revenue of $19.7 million, down 3% year-over-year and up 30% quarter-over-quarterQ4 gross profit increased 1% year-over-year to $12.5 million as gross margins increased from 61% to 63%Generated...
OptimizeRx.png
OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET
February 23, 2023 08:00 ET | OptimizeRx Corporation
ROCHESTER, Mich., Feb. 23, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx.png
OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
February 09, 2023 08:30 ET | OptimizeRx Corporation
ROCHESTER, Mich., Feb. 09, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx.png
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
January 04, 2023 07:30 ET | OptimizeRx Corporation
OPRX CEO Will Febbo provides business update and key industry trendsOPRX conference presentation to begin at 8:15 AM PT on January 12, 2023 ROCHESTER, Mich., Jan. 04, 2023 (GLOBE NEWSWIRE) --...
OptimizeRx.png
OptimizeRx to Participate in Upcoming Investor Conferences
November 28, 2022 09:31 ET | OptimizeRx Corporation
ROCHESTER, Mich., Nov. 28, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...